Dare Bioscience, Inc. (DARE) › Operating IncomeDare Bioscience, Inc. (DARE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$630.6K2017: -$11.18M2018: -$16.88M2019: -$14.34M2020: -$27.40M2021: -$39.07M2022: -$31.39M2023: -$30.94M2024: -$23.45M2025: -$13.55M-$13.55M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$13.55M+42.2%2024-$23.45M+24.2%2023-$30.94M+1.4%2022-$31.39M+19.7%2021-$39.07M-42.6%2020-$27.40M-91.0%2019-$14.34M+15.0%2018-$16.88M-51.0%2017-$11.18M-1673.0%2016-$630.6K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share